The World Pharmaceutical Excipient Market
Report Description
This study provides a global view of the pharmaceutical excipient sector. It describes the market trends and growth prospects, the supply and level of competition, as well as possible new entrants. The report provides a scientific and technical overview on the excipients’ bioavailability, main uses and the possible interactions and incompatibilities with a special consideration to Lactose. It provides data and market estimates in value and volume along with prices and main market trends. Also, based on a series of interviews with industrial players, the report profiles the main manufacturers and users in different parts of the world.
INGREDIENTS COVERED
Bioactive protein fractions
Bioactive peptides
Pharmaceutical excipients are compounds other than the active ingredients that are intentionally incorporated into pharmaceutical dosage forms. They play specific functional roles in the formulation of dosage forms. These excipients are derived from natural sources, synthesized chemically, or prepared semi-synthetically starting from natural sourced materials. Most formulations (70%-80%) contain excipients at a higher concentration than the active drug. currently excipients are used in various forms (tablets, pre-compression, granulation, liquids, caps, and inhalation products).
Â
There are thousands of excipients on the market but only hundreds are commonly used of which more than 90% are organic molecules such as sugars, starch derivatives, cellulose, and oleochemicals or petroleum derivatives. The rest of the market is occupied by inorganic chemicals (e.g. carbonates, calcium sulfates) and USP grade water for injectables. As a result, the market will be fragmented into organic excipients, inorganic excipients and United States Pharmacopeia (USP) water.
UBIC presents an analysis of the current and potential market of the pharmaceutical excipients. It also deals with the major market players with their detailed profiles. The scope of research covers countries worldwide. This study aims to provide a better knowledge of the pharmaceutical excipients’ market. This study also presents the scientific and regulatory aspect related to the pharmaceutical excipients. The following segmentation details the types of information that will be presented in the report:
- Request Brochure
-
- Objectives & Scope
-
INGREDIENTS COVERED
Bioactive protein fractions
Bioactive peptidesPharmaceutical excipients are compounds other than the active ingredients that are intentionally incorporated into pharmaceutical dosage forms. They play specific functional roles in the formulation of dosage forms. These excipients are derived from natural sources, synthesized chemically, or prepared semi-synthetically starting from natural sourced materials. Most formulations (70%-80%) contain excipients at a higher concentration than the active drug. currently excipients are used in various forms (tablets, pre-compression, granulation, liquids, caps, and inhalation products).
Â
There are thousands of excipients on the market but only hundreds are commonly used of which more than 90% are organic molecules such as sugars, starch derivatives, cellulose, and oleochemicals or petroleum derivatives. The rest of the market is occupied by inorganic chemicals (e.g. carbonates, calcium sulfates) and USP grade water for injectables. As a result, the market will be fragmented into organic excipients, inorganic excipients and United States Pharmacopeia (USP) water.
UBIC presents an analysis of the current and potential market of the pharmaceutical excipients. It also deals with the major market players with their detailed profiles. The scope of research covers countries worldwide. This study aims to provide a better knowledge of the pharmaceutical excipients’ market. This study also presents the scientific and regulatory aspect related to the pharmaceutical excipients. The following segmentation details the types of information that will be presented in the report:
- Methodology
-